BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$337M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$172M |
| 4 |
PPG Industries
PPG
|
+$132M |
| 5 |
AGN
Allergan plc
AGN
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 3 |
Apple
AAPL
|
+$317M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$275M |
| 5 |
McDonald's
MCD
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.71% |
| 2 | Financials | 8.23% |
| 3 | Healthcare | 5.81% |
| 4 | Consumer Discretionary | 5.23% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZINC
2951
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $40.2K | ﹤0.01% |
13,231
-1,483
| -10% | -$11.2K |
|
2952
Glaukos
GKOS
$11.1B
| $40.1K | ﹤0.01% |
+1,659
| New | +$49.9K |
|
|
AIOT
2953
PowerFleet Inc
AIOT
$420M
| $40.1K | ﹤0.01% |
12,500
-2,500
| -17% | -$11K |
|
|
TRR
2954
DELISTED
Trc Companies
TRR
| $40.1K | ﹤0.01% |
3,391
+1,968
| +138% | +$20.2K |
|
|
BELFB
2955
Bel Fuse Inc Class B
BELFB
$4.19B
| $40K | ﹤0.01% |
2,060
+1,199
| +139% | +$24K |
|
|
ZAGG
2956
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $40K | ﹤0.01% |
5,894
+3,437
| +140% | +$25.8K |
|
2957
Addus HomeCare
ADUS
$2.18B
| $39.8K | ﹤0.01% |
1,278
+743
| +139% | +$21.8K |
|
2958
Limoneira
LMNR
$253M
| $39.8K | ﹤0.01% |
2,378
+1,421
| +148% | +$27.2K |
|
|
VVUS
2959
DELISTED
Vivus Inc
VVUS
| $39.8K | ﹤0.01% |
2,424
+1,560
| +181% | +$24.7K |
|
|
CSCD
2960
DELISTED
CASCADE MICROTECH, INC.
CSCD
| $39.7K | ﹤0.01% |
2,811
+1,680
| +149% | +$24.5K |
|
|
FFKT
2961
DELISTED
Farmers Capital Bank Corp
FFKT
| $39.7K | ﹤0.01% |
1,598
+975
| +157% | +$25.9K |
|
2962
Lazard
LAZ
$4.47B
| $39.6K | ﹤0.01% |
915
-8,616
| -90% | -$444K |
|
2963
Tiptree Inc
TIPT
$678M
| $39.6K | ﹤0.01% |
6,190
+3,700
| +149% | +$23.2K |
|
|
EVDY
2964
DELISTED
Everyday Health, Inc.
EVDY
| $39.6K | ﹤0.01% |
4,328
+2,532
| +141% | +$27.7K |
|
|
KDNY
2965
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $39.6K | ﹤0.01% |
+408
| New | +$48.6K |
|
|
CCXI
2966
DELISTED
ChemoCentryx, Inc.
CCXI
| $39.5K | ﹤0.01% |
6,532
+4,205
| +181% | +$30.4K |
|
2967
Morningstar
MORN
$7.75B
| $39.5K | ﹤0.01% |
492
-951
| -66% | -$77.6K |
|
|
NPTN
2968
DELISTED
NEOPHOTONICS CORP
NPTN
| $39.3K | ﹤0.01% |
5,775
+3,452
| +149% | +$26.7K |
|
2969
Lineage Cell Therapeutics
LCTX
$268M
| $39.3K | ﹤0.01% |
16,339
+10,833
| +197% | +$28K |
|
2970
Cardiff Oncology
CRDF
$76.7M
| $39.3K | ﹤0.01% |
96
+68
| +243% | +$35.6K |
|
2971
Noodles & Co
NDLS
$105M
| $39.3K | ﹤0.01% |
347
+215
| +163% | +$23.4K |
|
2972
Teladoc Health
TDOC
$1.25B
| $39.3K | ﹤0.01% |
+1,761
| New | +$47.6K |
|
2973
Geospace Technologies
GEOS
$71.3M
| $39.2K | ﹤0.01% |
2,839
+1,745
| +160% | +$29K |
|
2974
Evolent Health
EVH
$521M
| $39.2K | ﹤0.01% |
+2,455
| New | +$47.9K |
|
|
CUTR
2975
DELISTED
Cutera, Inc.
CUTR
| $39.2K | ﹤0.01% |
2,994
+1,789
| +148% | +$26.6K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2015 Portfolio in Review
As of Q3 2015, BNP Paribas Financial Markets held 3,791 positions worth $39.9B, up 11% from $35.8B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
BNP Paribas Financial Markets deployed $7.43B of net new capital in Q3 2015, opening 248 new positions and adding to 2,429 existing holdings. Its largest new stake was Allergan plc: 397,434 shares worth $108M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 10% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $525M trimmed.
- BNP Paribas Financial Markets's largest Q3 2015 buy was Allergan plc: 397,434 shares worth $108M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $5.63B increase.
- BNP Paribas Financial Markets's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $525M.
- BNP Paribas Financial Markets fully exited Canadian National Railway in Q3 2015, selling an estimated $750M.
- BNP Paribas Financial Markets's ten largest holdings make up 45% of its $39.9B portfolio in Q3 2015.
- BNP Paribas Financial Markets opened 248 new positions and closed 172 in Q3 2015.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $39.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.